-
Racial and ethnic differences in patients with Parkinson’s Disease across Parkinson’s Disease Centers of Excellence
-
Randomised Controlled Trial Comparing Efficacy of Zonisamide 25 mg given in addition to standard treatment with standard treatment alone in Tremor dominant Parkinson’s Disease- A Pilot study.
-
Randomized, Placebo-Controlled Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of ABBV-0805, an Anti-Alpha-Synuclein Monoclonal Antibody in Healthy Subjects
-
Rapamycin attenuates nigral and hippocampal alpha-synuclein accumulation in AAV-mediated alpha-synuclein overexpression model of Parkinson’s disease
-
Rapid blinking as an early clinical marker of Parkinson’s disease
-
Rapid Onset Stiff Person Syndrome
-
Rapidly progressive dementia after MRI-guided Focused Ultrasound (MR-FUS)
-
Rare Neurodegenerative Phenotypes in Patients Carrying Homozygous GBA1 Mutations
-
Rare UQCRC1 variants in Chinese patients with Early Onset Parkinson’s Disease
-
Re-thinking enrollment of Deep Brain Stimulation patients in Parkinson’s Disease Clinical Trials
-
Real-world characteristics of advanced Parkinson’s disease patients initiating carbidopa/levodopa enteral suspension
-
Real-World Deep Brain Stimulation Outcomes Using Directional DBS Systems with Multiple Independent Current Control
-
Real-World Evidence Supports use of Transcutaneous Afferent Patterned Stimulation for Tremor Control in Veteran’s Affairs Essential Tremor Patients
-
Real-World Outcomes Using a Novel Directional Lead from a Multicenter DBS Registry for Parkinson’s Disease
-
Reanalysis of a Patient-Reported Outcome (Tardive Dyskinesia Impact Scale) Shows Positive Results
-
Reasons for refusing deep brain stimulation in patients with Parkinson’s disease: a retrospective 10-year study
-
Recent advances in Physiotherapy management of Higher level Gait disorders among older adults: A narrative review of literature
-
Reduced Alpha suppression & altered EEG signal complexity in Parkinson’s disease – signatures of cognitive impairment?
-
Reduced cerebral energy metabolism in Parkinson’s disease in contrast to Progressive Supranuclear Palsy
-
Reduced serum PRDX3 levels are a biomarker for Asian LRRK2 carriers in Parkinson’s disease
-
Reducing anxiety improves freezing of gait in Parkinson’s disease patients
-
Regional brain iron and gene expression variation in Parkinson’s disease
-
Registry Analysis (In Progress) to Evaluate Clinical Outcomes and Disease Burden of Advanced PD in Patients With Motor Fluctuations and Dyskinesia Managed With Oral Dopaminergic Therapies Versus Device-Aided Therapies
-
RELATION BETWEEN COGNITIVE INHIBITORY CONTROL AND ANTICIPATORY POSTURAL ADJUSTMENT DURING A CONFLICTUAL STEP INITIATION TASK IN PARKINSON’S DISEASE INDIVIDUALS.
-
Relationship between frequency and severity of REM sleep behavior disorder and clinical features in patients with Parkinson’s disease
-
Relationship Between Hyposmia and Olfactory Network Connectivity in Patients With Parkinson’s Disease
-
Relationship between low back pain-related disability and motor performance in people with Parkinson disease
-
Relationship of satisfaction and adherence in remote digital monitoring: Results from a clinical drug trial in early Parkinson’s disease
-
Relationship of subcortical iron deposition and mitochondrial dysfunction in patients with idiopathic Parkinson’s disease
-
Reliability and Validity of the Greek Translation of the Scale for Assessment and Rating Ataxia in Ataxic Children
-
REM sleep without atonia and nocturnal body position in prediagnostic Parkinson’s disease
-
Remote Art Therapy is feasible and may benefit individuals with Parkinson’s disease
-
Remote assessment of prodromal Parkinson’s disease in a LRRK2 G2019S cohort
-
Repeated gait perturbation training in healthy older adults and people with Parkinson’s disease. A systematic review and meta-analysis.
-
Reproductive factors and risk of Parkinson’s disease in women: preliminary results from the French prospective cohort E3N.
-
RESPONDING TO COVID-19: THE “ALMEIDA-SANG EQUATION” TO PREDICT TOTAL DISEASE SEVERITY IN PARKINSON’S
-
Resting state functional connectivity networks related to MDS-UPDRS motor outcomes in Parkinson’s Disease
-
Resting state functional MRI network assortativity is increased in Parkinson’s disease
-
Resting-state connectivity predictors for prefrontal cortex activity during walking in Parkinson’s disease.
-
Restless Leg Syndrome After Propranolol Intake: A Single Case
-
Restless leg syndrome and atherosclerosis: prospective study in the Canadian Longitudinal Study on Aging
-
Retrospective Review of Globus Pallidus Deep Brain Stimulation Electrode Contact Locations and Clinical Outcomes in Parkinson’s Disease
-
Retrospective review of MRI-guided focused ultrasound (MRgFUS) thalamotomy referrals: updated experience from a single movement disorder center
-
Reversible hemichorea due to contralateral anterior cerebral artery territory hypoperfusion
-
Reversible MIBG Abnormalities in Subjects at Risk for Synucleinopathy: 12 months data
-
Review of intraoperative computed tomography accuracy for deep brain stimulation lead verification
-
Risk and timing of manifest Huntington’s disease in patients with reduced penetrance alleles
-
RISK FACTORS FOR FALLS AMONG PEOPLE WITH PARKINSON ʼS DISEASE
-
Risk factors for the onset of dyskinesia in patients with Parkinson’s disease exhibiting wearing-off phenomena: A 1-year observational study in Japan (J-FIRST)
-
Risk of cancer in Parkinsons’s disease: a systematic review of diagnostic validity
-
Risk of Tardive Dyskinesia in Patients with Tic Disorders: Preliminary Results
-
RNA Editing in Parkinson’s Disease Shows Changes in Mitochondrial and Manganese-Binding Pathways in Multiple Brain Regions
-
Role of S100B in the Pathogenesis of Parkinson’s Disease
-
Role of Selective Serotonin Reuptake Inhibitors in the Management of Motor Tics in Tourette’s Syndrome
-
Role of the Stereotactic Dentatotomy for the management of Movement Disorders
-
Role of Uric Acid in Friedreich Ataxia neurodegeneration
MDS Virtual Congress 2021
September 17-22, 2021. Virtual Congress. www.mdscongress.org